Andrew D.c. LaFrence - 10 Jul 2023 Form 3 Insider Report for KORU Medical Systems, Inc. (KRMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
18 Jul 2023, 20:47:04 UTC
Prior SEC filing
17 Mar 2022
Next SEC filing
18 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew D. C. LaFrence

Key filing fact

Andrew D.c. LaFrence filed Form 3 for KORU Medical Systems, Inc. (KRMD) on 18 Jul 2023.

Key facts

  • This page summarizes Andrew D.c. LaFrence's Form 3 filing for KORU Medical Systems, Inc. (KRMD).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Jul 2023, 20:47.

Change

  • Previous filing in this sequence was filed on 17 Mar 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
10 Jul 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRMD holding Derivative

Option to Purchase Shares of Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
10 Jul 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$2.95
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 07/15/2023 date of grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .